Background. Hidradenitis suppurativa (HS) is a chronic skin disease. The symptoms can be
B. Introduction
Hidradenitis suppurativa (HS), also known as acne inversa, is a severe and disfiguring skin disease. The prevalence in Caucasians is estimated to be as high as 1%, making it as prevalent as well-recognized skin diseases such as psoriasis and atopic dermatitis 1, 2 . The first onset of symptoms typically occurs after puberty, in the teens and early 20s. The disease course is chronic with periodic relapses. The most frequently affected areas are the axillae, groin, pubic area, and inner thighs 3 . Lesions can affect the perianal region, as well as the submammary and inframammary folds. The mildest form of HS consists of inflamed and painful nodules or lumps.
In more severe forms of HS, the painful lesions progress to full abscesses. Multiple, adjacent abscesses form communicating subcutaneous sinus tracts that drain a purulent, malodorous fluid. The chronic course and severity of lesions leads to hypertrophic scarring. These lesions are intensely painful and significantly reduce quality of life in affected individuals [4] [5] [6] [7] .
In 1985, Fitzsimmons and Guilbert showed evidence for a Mendelian-like pattern of autosomal dominant HS in some families 8 . Between 20-40% of individuals with sporadic HS ascertained from multiple populations report having at least one affected relative as well, suggesting an appreciable genetic risk 4, [9] [10] [11] . One of the first strong linkage regions was mapped to chromosome 1 between D1S248 and D1S2711 in three generations of a Chinese kindred with autosomal dominant HS (hg19 g.chr1:107154920-185518094; 78 Mb) 12 . Rare genetic variants in components of the γ-secretase complex have since been discovered in some kindred with familial HS (fHS). Active γ-secretase requires nicastrin (NCSTN), anterior pharynxdefective 1 (APH1A or APH1B), presenilin enhancer gamma secretase subunit (PEN2), and a presenilin (PSEN1 or PSEN2). Both NCSTN and APH1A fall within the initially reported linkage region. Variants linked to fHS have been identified in PSEN1, PSENEN (the PEN2 gene), and NCSTN (OMIMs #142690, #613736, #613737) [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . The majority of these variants are in NCSTN, and the same premature termination variant has even been reported in both a Chinese family and an African American family with autosomal dominant HS 13, 14 . Novel variants have also been discovered in sporadic cases with no self-reported family history of disease, but the significance of these variants is not yet clear 9 . In some studies only a minority of fHS kindred (20-30%) have an identified loss-of-function variant in γ-secretase components 17, 18 . This suggests that much of the genetic contribution to fHS has therefore not been identified, further confounding both the identification of loss-of-function variants in sporadic HS cases and the development of therapeutics.
The γ-secretase complex cleaves type-1 single-pass transmembrane proteins. Stable complex formation requires a presenilin to be stabilized by APH1 and NCSTN, followed by interaction with PEN2 23, 24 . Yeast, which lack γ-secretase, can form active γ-secretase complexes with exogenous overexpression of the individual components 23 . Substrates for the complex have both an intracellular (cytoplasmic domain) and extracellular (ectodomain) portion. 13, 17 . To assess the biological impact of NCSTN haploinsufficiency we used shRNA to knockdown NCSTN in a human epidermal keratinocyte cell line (HEK001) and a human embryonic kidney line (HEK293), and profiled the transcriptomes via microarray. We later generated a heterozygous NCSTN deletion in HEK293 cells. Our overall approach is diagrammed in Supp. Fig. 1 . Surprisingly, we discovered that reduced nicastrin caused disrupted interferon signaling in both cell lines after transduction with lentivirus and selection for knockdown cells, which raises the question of what systemic effects exist for individuals with familial HS.
C. Materials & Methods

C.1. Cell culture
We obtained HEK001, HEK293, and HEK293T lines from the ATCC, and cultured them at 37°C with 5% CO 2 . We cultured the HEK293 and HEK293T cells in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 units/mL penicillin and 100 µg/mL streptomycin. We cultured HEK001 cells in Keratinocyte-SFM (serumfree medium) supplemented with human recombinant Epidermal Growth Factor and Bovine
Pituitary Extract (Life Technology #17005042).
C.2. shRNA transfection
We transfected HEK293T cells (40-70% confluence) using the TransIT-LT1 system according to the manufacturer's instructions (Mirus). The transfection mix contained 1 µg of shRNA hairpin plasmid and 1 µg of an 8:1 ratio of packaging plasmid (pCMF-dR8.2) and envelope plasmid (pCMV-VSV-G). After 24 hours, we removed the transfection mix and switched to 6 mL of fresh media. After another 24 hours, we collected the media, centrifuged at 1250 xɡ for 5 minutes, and saved the supernatant containing lentivirus.
We infected HEK001 or HEK293 cells (~70% confluence) with the lentivirus containing supernatant diluted 1:5 with complete cell culture media plus polybrene at a final concentration of 10 µg/mL. After 24 hours, we discarded the media, and replaced it with media containing puromycin. We selected HEK293 cells using 2 µg/mL puromycin and HEK001 with 0.5 µg/mL.
When cultures were nearing confluence, we split them 1:10 with fresh media containing puromycin (twice in two weeks). We extracted RNA from the final cultures using the miRNeasy mini kit (Qiagen, #217004) according to the manufacturer's instructions.
C.3. RT-qPCR
We generated cDNA using Superscript II according to the suggested manufacturer guidelines.
This included using the included buffers and dNTP mixes with 6 µM random hexamer primers, 200 U of reverse transcriptase (RT), and up to 1 µg of total RNA. We incubated samples at 25°C for 10 minutes to anneal primers, 55°C for 1 hour for synthesis, and heat inactivated the RT at 70°C for 10 minutes. For RT-qPCR, we used 0.6 ng of cDNA as template with 1X SYBR Green, and 100 nM each forward and reverse primer. The reactions were incubated for 10 minutes at 95°C for initial denaturation, had up to 40 cycles of 30 second denaturation at 95°C, 45 seconds at 65°C for annealing, and 30 seconds at 78°C for extension, followed by a final 10 minute 78°C extension, and hold forever at 4°C. For relative expression, we ran at least 3
replicates of each sample-amplicon, and used the delta-delta Ct method compared to 18S rRNA to determine relative expression. We exported the quantification cycle (Cq) of each well and propagated standard deviation to determine the final relative expression difference. The primer sequences and details of the error propagation procedure for relative expression changes can be found in the supplementary material.
C.4. Microarray differential expression analysis
We analyzed the microarray data with the Bioconductor (v2.36.2) beadarray package (v2.26.1) using R (v3.4.0) and R Studio (v1.0.143). We used non-normalized, background subtracted array data as input, keeping only probes with a detection p-value < 0.05 in at least three samples. We shifted the distribution of each array by adding or subtracting a constant such that the minimum intensity value was 2.0, since background subtraction can result in negative intensities. We transformed the shifted data by log 2 , and normalized by quantile normalization.
We determined differential expression using the limma (v3.32.5) package with the specified model (NCSTN knockdown -luciferase knockdown). We considered a gene differentially expressed if the false-discovery rate corrected p-value was less than 0.05.
We used the gProfileR g:COSt tools to analyze for pathway enrichment 25 . We included genes with a significant corrected p-value and a minimum absolute fold-change of 1.50 in pathway analyses, and analyzed genes with decreased expression separately from those with increased expression. We entered genes by RefSeq NM number rather than the gene symbol to avoid ambiguity with gene names. We ran all enrichments using the following options:
significant enrichments only, run as ordered query, no electronic GO annotations, medium Omnibus (GEO; GSE57949).
C.5. NFKB luciferase assay
We plated the HEK293 cells at a density of 100,000 cells per well in a 24-well plate 24 hours prior to transfection. We transfected cells using the transIT-LT1 system (described above) with NFKB-luc (firefly luciferase construct containing proximal NFKB binding sites) and renilla luciferase (pGL4 as a transfection control) at a ratio of 24/1. Four hours later we treated some cultures with TNF (Sigma #T0157) at 20 ng/mL. Twenty-four hours post-transfection, we harvested the cells and assayed both firefly luciferase and renilla luciferase activity using the Dual-Luciferase Reporter Assay System (Promega). We calculated statistical significance for NFKB induction (firefly / renilla) in R using Tukey Honest Simple Differences of the ANOVA model.
C.6. Growth curves
We plated cells at 3,000 cells/well in standard complete culture medium (see Cell culture) and measured proliferation starting the second day for up to 7 consecutive days using a colorimetric assay according to the manufacturer's instructions (CellTiter 96 Non-Radioactive Cell Proliferation Assay). We detected the color change by absorbance at 570 nm in 96-well plate reader (uQuant). Each day's measurement had a background measurement subtracted. We calculated within day / within cell type significance by two-sided t-test.
C.7. Genome editing
We generated NCSTN knockouts in HEK293 cells with CRISPR/Cas9 based genome-editing.
We modified the guide RNA scaffold to include a T>A swap (Flip) and an extended stem (Extension), called the Flip + Extension (F+E) guide, as previously described 26 . We targeted NCSTN with guide sequence GGCATACTGTACAACATAAG (g.chr1:160326441-160326460; hg19). We ordered the modified gRNA scaffold with our guide as an IDT gBlock for blunt-end cloning with the pCR-Blunt II-TOPO vector (Supp. Table 2 ). We amplified the guide RNA stock using PCR to obtain sufficient amounts for cloning. We also ordered a donor gBlock to insert a stop-codon in NCSTN in case homology-directed repair was favored over non-homologous endjoining (Supp. Table 3 ). We amplified the donor using PCR to prior to transfection as well. We plated HEK293 cells at a density of 350,000 cells/well in 6-well plates the day prior to transfection. We then transfected them using the LT-1 system with 0.75 µg each of humanized Cas9 plasmid (Joung lab; AddGene JDS246, plasmid #43861), guide RNA, and a donor amplicon.
After 24 hours incubation, we plated the cells in fresh media at 50,000 cells / 15 cm culture plate to dilute cells into single-cell clones. We picked samples from clonal clusters one week later, and transferred them to individual wells in a 96-well plate. We sampled a scraping from individual wells, and amplified the target region by PCR. One sample (clone 48) had a potential frameshift by Sanger sequencing. RT-qPCR confirmed less NCSTN mRNA compared to wildtype HEK293 cells.
D. Results
D.1. NCSTN mRNA can be reduced to less than 50% wildtype levels using shRNA
We tested five separate shRNA constructs (A06-A10; Supp. Table 4) for their ability to knockdown NCSTN mRNA levels in the HEK001 and HEK293 cell lines (Fig. 1) . We used two different NCSTN amplicons for each shRNA and tested for relative expression differences using realtime quantitative PCR (RT-qPCR).
Only shRNA constructs A08 and A09 demonstrated consistent, strong reduction of NCSTN mRNA for each amplicon in both cell lines. shRNA A08 demonstrated the strongest knockdown and was used for further study. We generated stable knockdowns in both HEK001 and HEK293 for A08 and a control shRNA (shLuc; targeting luciferase). We generated each stable line in triplicate and selected for retention of the shRNA plasmid for two weeks in puromycin. We confirmed the knockdown (Supp. Fig. 2 ) and used the shLuc and shA08 line RNAs for array-based transcriptome . The x-axis is the shRNA construct used, and the y-axis is the relative expression to non-transduced controls. Points indicate mean relative expression and error bars represent standard deviation. Grey boxes indicate the standard deviation of the control cells. We tested two different NCSTN amplicons (circle and triangle) and each tested amplicon had 3 technical replicates. A08 had the most consistent knockdown effect.
profiling. We later generated an shGFP (shRNA targeting green fluorescent protein) stable knockdown for use in luciferase assays.
D.2. HEK001 keratinocyte NCSTN knockdown lines have increased type-I interferon activation and disruption of cell cycle related genes
HEK001 knockdown of NCSTN resulted in the differential expression of 1,548 probes for 1,393
unique genes ( Fig. 2A ; Supp. Table 8 ). We confirmed a subset of these by RT-qPCR (Supp.
Fig. 3).
We focused on those genes with an adjusted p-value < 0.05 and an absolute foldchange (FC) of at least 1.50 (n=364 increased, n=324 decreased). Significant fold-changes ranged from -8.04 (nicastrin, NCSTN) to 5.58 (fibroblast growth factor receptor 3, FGFR3).
Fig. 2 -Volcano plot of differentially expressed genes with knockdown
Volcano plots for the HEK001 (A) and HEK293 (B) knockdowns. The effect size is shown on the x-axis (log2 foldchange) and the adjusted significance on the y-axis. Some top genes are individually labeled. The horizontal line represents adjusted p-value of 0.05, and the vertical lines represent 1.5-fold changes.
We tested significant genes with at least a -1.5-fold decreased expression for enrichment of known pathways. We found enrichment of genes related to cell cycle (Supp. Fig.   4A ; Supp. We separately tested the genes with at least a 1.5-fold significantly increased expression for enrichment. Instead of cell cycle related functions, we found enrichment for type-I interferon responses (Supp. Fig. 4B ; Supp. Table 10 
D.3. HEK293 NCSTN knockdowns have decreased NOTCH and interferon signaling
The HEK293 cell lines exhibited more transcriptome changes in response to knockdown of NCSTN. Overall, 3,089 probes for 2,813 genes were significantly differentially expressed ( Fig.   2B ; Supp. Table 11 ). More than 1,300 genes exhibited at least an absolute 1.5-fold change (n=607 up, n=784 down), and the largest changes ranged from -6.6 FC (insulin-like growth factor binding protein 5, IGFBP5) to 11.6 FC (annexin a1, ANXA1). Again, we confirmed a subset of changes by RT-qPCR (Supp. Fig. 5) .
As before, we tested for enrichment of known molecular pathways. Genes decreased in the HEK293s were enriched for small molecule and steroid biosynthesis (Supp. Fig. 6A ; Supp. The genes with increased expression were primarily enriched for categories related to senescence, HDAC activity, and methylation (Supp. Fig. 6B ; Supp. There was no statistical difference for knockdowns in either cell line during the initial exponential growth phase (Fig. 3) . However, knockdowns of both lines demonstrated significantly reduced signal in the post-exponential phase (Supp. Table 5 ). It's worth noting that the non-radioactive assay we used relies on conversion of an input substrate into a product with different absorbance spectra. Therefore the significantly reduced activity demonstrates reduced
Fig. 3 -Proliferation assay reagent conversion disrupted in NCSTN knockdowns
We tested knockdowns in both cell types for proliferation by colorimetric substrate conversion assay. The x-axis is the day post plating and the y-axis is the backgroundsubtracted absorbance. The shRNAs are differentiated by shape and color. The points represent the mean and error bars are the standard deviation. Each was based on 3 replicates. Any differences within a time point by t-test are indicated by solid horizontal lines with asterisks. Three late HEK001 and two late HEK293 time points are slightly but significantly lower.
conversion, which could be driven by increased cell death, increased rates of senescence, or a mixture of the two.
D.5. HEK293 cell lines have altered NFKB activation with decreased NCSTN
In sporadic HS, suppressing TNF with anti-TNF monoclonal antibodies can be an effective treatment. Given the misregulation of inflammatory genes in our NCSTN knockdown cell lines, we were curious whether a pathway downstream of TNF, particularly the NFKB response, was activated in our cells. To assess the effect of NCSTN depletion on NFKB signaling, we transfected our HEK293 knockdown cells with a plasmid containing luciferase under the control of an NFKB inducible promoter. We tested three stable knockdowns (A08, shLuc, shGFP) with no treatment and after stimulation with TNF ( Fig. 4 ; Supp. Table 6 ). The A08 line demonstrated significantly increased NFKB activity compared to both the shLuc and shGFP constructs when no stimulation was used (1.7-to 1.9-fold). All of the TNF stimulated lines had significantly increased NFKB activity compared to all the unstimulated lines. However, there was no difference amongst the TNF stimulated samples. Table 7) .
It is possible that the increased baseline activity is not directly attributable to NCSTN
As before, all of the TNF These results suggest that knockdown of NCSTN expression in HEK293 results in dysregulated NFKB expression. We did observe a discrepancy with regards to whether the dysregulation was observed at baseline or after TNF stimulation. This discrepancy might be a result of the intrinsic differences of the two models. It is possible that the exposure of cells to lentivirus for shRNA delivery provides a stimulus to expose the NFKB misregulation at baseline, whereas without exposure to lentivirus TNF stimulation is needed to observe the NFKB misregulation.
E. Discussion
The natural history of HS lesion development is understudied. The basic mechanisms of pathogenesis are still controversial, with multiple competing hypotheses. The name "hidradenitis" was used because glandular inflammation was thought to be a key initiating role.
However, even this may be a misnomer. It has been previously shown that an HS-like Results of NFKB driven luciferase activity in wildtype HEK293 (WT) and a partial genomic deletion line (Het. Deletion). The treatment is on the x-axis and the yaxis is relative fluorescence units (RFU). We tested triplicates of each treatment in each line, represented by the individual dots. Cell lines are differentiated by dot shape and color. Lines with asterisks indicate significant differences in activity (P < 0.05). There was no difference in baseline NFKB activity, but the deletion line has significantly increased NFKB activity after TNF stimulation.
phenotype can be produced simply by applying occlusive tape, suggesting that perhaps follicular occlusion is the initiating step 27 . Histological studies have confirmed that follicular occlusion, rather than apocrinitis, is the most common feature of affected HS skin 28, 29 , and that the follicles within a lesion may have weak basement membranes that are prone to rupture 30 .
The rupturing of an occluded follicle alone could initiate an inflammatory response, which could be further amplified by bacterial invasion of the compromised follicle.
How would this mechanism fit with a genetic haploinsufficiency of nicastrin in familial HS? One possibility could be related to cell growth. HS lesions also epithelial hyperplasia, hyperkeratosis, and acanthosis 28, 29 . In familial HS, disrupted gamma-secretase function might lead to keratinocyte overgrowth that directly contributes to occlusion of follicles. Decreased cell growth in follicular basement membranes, or otherwise weaker basement membrane structure, could promote a greater frequency of follicular rupture. Another possibility is that HS disease presentation could result from increased magnitude or duration of inflammatory response in response to an occluded follicle.
Human cell lines have obvious limitations, particularly due to chaotic rearrangements, unstable genomes, and variable ploidy. They do, however, provide a tractable system for the assay and treatment of human cells. The data we generated using these resources raise interesting questions to be pursued further in primary human cells and affected human tissue.
One interesting finding is the strong increase in type-I interferon signaling in HEK001 keratinocyte knockdowns. We used a pantropic lentivirus to transduce the shRNA plasmids into the cell lines which may trigger an interferon response. However, since the effect was only seen in the keratinocytes with NCSTN knockdown, it must not be a general feature of lentivirus stimulation. It also was not observed in the HEK293 knockdown lines, indicating the effect must have some cell-type specificity. The interferon response also would not be in response to continued viral replication as the system we use does not produce replication-competent lentivirus. This raises the question of whether individuals with NCSTN haploinsufficiency have misregulated inflammatory responses. Do specific cell types in these individuals produce prolonged cytokine / chemokine signaling after initial stimulation, and could this mechanism underlie some of their disease phenotype? We have previously helped describe keratinocyte hyperinflammatory responses in individuals with familial psoriasis driven by rare variants in CARD14, supporting this possibility 31, 32 . It will be interesting to evaluate whether local misregulated keratinocyte signaling may play a key in perpetuating familial HS lesions.
Something we did not observe in our keratinocyte lines was an equally compelling signature for NOTCH signaling. While the essential role for gamma-secretase regulation of NOTCH signaling is well-established, there is little direct evidence that NCSTN haploinsufficiency instigates HS disease through decreased NOTCH signaling. Furthermore, several studies have shown in vitro that NCSTN is not essential for processing all gammasecretase substrates 33, 34 . One study evaluating primary cells from individuals with NCSTN haploinsufficiency found no decrease in the number of gamma-secretase complexes formed in haploinsufficient cells 35 . And another study found that 3 of 4 NCSTN missense mutations associated with familial HS disease are still able to facilitate NOTCH signaling 36 . It is also worth noting that a previous array-based gene expression study comparing lesional HS skin (n=17) to non-lesional HS skin (n=13) discerned a strong signal for increased inflammation in lesional skin without a strong enrichment for NOTCH signaling 37 . In contrast, previous work using siRNA prevalence, approaching 20% in some cohorts 11, 39 . HS has also recently been shown to be more common in axial spondyloarthritis patients 40 .
In one study a TNF promoter SNP (rs361525) was enriched in a small cohort of HS patients compared to controls 40 , and this allele also is associated with risk for psoriasis 41 . Higher levels of TNF have been observed in HS lesional skin as well 42 .
Another intriguing phenotype uncovered with our study is altered growth / cell division in NOTCH signaling of course cannot be excluded as a driving force in pathogenesis, but inflammation may play an independent role. Indeed, there may be time-course specific progression during HS lesion development that involves NOTCH signaling initially, but eventually is driven by inflammatory stimulus. It will be important to ultimately help distinguish whether familial HS is similar to sporadic HS, sharing similar pathological mechanisms, or whether it is a severe phenocopy with unique mechanisms. Further study in patient tissue and in primary cell lines will be required to help tease apart these possibilities.
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H.1.1. Propagating standard deviation in ddCq measurements
For all of our RT-qPCR experiments, we set up at least 3 technical replicates per gene, and for each panel of tested genes included an 18S rRNA reference amplicon. We were ultimately interested in the relative expression difference of our test condition versus control condition, and calculated this metric using the "delta delta Ct" method, which we will call ddCq for quantification cycle (Cq) rather than threshold cycle (Ct). First, we calculated the mean (x) and standard deviation (s) for each set of technical replicates. Next, we calculated the difference between the quantification cycles (dCq) of the gene of interest and the reference gene (18S rRNA).
Subtracting the means is simple, but both values have their own variability estimates (standard deviation).
The second delta step involves solving for the difference in dCq values between the test shRNA and the control shRNA (ddCq). As before, subtracting the means is simple, and the standard deviations should be propagated similarly.
We can calculate the relative fold-change between conditions by raising 2 to the negative mean ddCq value. However, the standard deviation propagation is slightly different since we are now raising a constant to a power with error.
The final relative expression value therefore estimates the mean fold-change along with an error propagated measure of variability.
H.1.2. Propagating standard deviation for colorimetric assay fold-changes
We calculated the mean (x) and standard deviation (s) for the proliferation assay values.
Calculating the fold-change between each condition therefore involves dividing the mean absorbance values.
However, in this case since division is involved, we propagate the standard deviation as relative error.
H.1.3. Characterizing the genomic deletion line
We screened several single-cell dilution clones after the transfection of our homology-directed repair construct, single-guide RNA plasmid, and Cas9 plasmid. Clone 48 showed a frameshifting deletion by Sanger sequencing, characterized by chaotic overlapping peaks. We amplified the target region using the NCSTN editing amplicon primers, and generated an amplicon sequencing library by the TruSeq method (ligate Illumina TruSeq adapters to the amplicon A-overhang). We uniquely indexed amplicons from wildtype (WT) HEK293 cells and the edited clone, and sequenced the amplicon as a spiked in sample on an Illumina MiSeq in 2x250 mode. Amplicon sequencing is available in the Sequence Read Archive (BioProject PRJNA268374). This generated ~168,000 reads for the wild-type cells and ~153,000 reads for the deletion clone. We cleaned the data up with cutadapt (v1.14) by removing contaminating sequencing adapter, trimming bases with qualities < 20, and requiring a minimum trimmed length of 50 bp. We aligned the cleaned data to the b37 (Broad GRCh37 + decoy contigs) with bwa mem (0.7.10-r789). Approximately 98% of all reads mapped appropriately by samtools flagstat (v0.1.19-44428cd).
We ran pindel (v0. by a large increase in coverage in the center of the amplicon (Supp. Fig. 8) . However, the deletion line showed a decreased coverage over these and surrounding regions. In fact, zooming in on the coverage within the amplicon shows the likely cut site to be 4 bases internal to the single-guide RNA target, suggested successful editing. While additional work would be needed to resolve the duplicated partial copies of NCSTN (or partial internal duplication in
